- Home
- RGS vs BRNS Comparison
RGS vs BRNS Comparison
Compare RGS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGS | BRNS |
|---|---|---|
| Founded | 1922 | 2016 |
| Country | United States | United Kingdom |
| Employees | 1745 | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.9M | 55.9M |
| IPO Year | 1991 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RGS | BRNS |
|---|---|---|
| Price | $27.39 | $0.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 5.0K | ★ 75.2K |
| Earning Date | 02-11-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.05 | N/A |
| EPS | ★ 45.08 | N/A |
| Revenue | ★ $223,032,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.64 | ★ N/A |
| Revenue Growth | 13.98 | ★ 1766.46 |
| 52 Week Low | $15.00 | $0.64 |
| 52 Week High | $31.50 | $2.92 |
Technical Indicators
Market Signals| Indicator | RGS | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 41.43 |
| Support Level | $28.04 | $0.68 |
| Resistance Level | $30.17 | $0.74 |
| Average True Range (ATR) | 0.83 | 0.06 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 0.00 | 48.02 |
Price Performance
Historical ComparisonAbout RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.